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A Selective Approach to Bleeding Esophageal Varices!
Glyn G, Jamieson, MD,* Irwin B. Faris, MD,* and John Ludbrook, MD*

It is possible that the best results of treatment for bleeding
esophageal varices will come when a selective approach is
used. In patients bleeding acutely and in patients with poor
liver function shunt operations should be avoided, and a
direct attack on the varices with either sclerosant therapy.

percutaneous obliteration, or staple gun gastro-esophageal
transsection should be carried out. In patients who have
stopped bleeding, or those in whom elective treatment is
being undertaken, the best operation at present appears to
be selective distal splenorenal shunt.

History of the Portacaval Shunt

ication" (since designated hepatic encephalopathy by
Sheila Sherlock).

In 1876 B.F Lautenbach first suggested joining the portal
venous system to the systemic venous system for the treatment of ascites. When an abstract of his report was published in Russia, Nicolai Vladimirovich Eck used it to carry
out such an anastomosis (1), the first report in the literature.

In the human, the first shunt between the portal and
systemic systems was performed by the French surgeon
Vidal and reported in 1902. He noted that unless protein
was excluded from his patient's diet, the patient became
severely intoxicated (2). Although Vidal's patient lived for
several years, the problem of "meat intoxication" as well
as the high mortality rate of the operation prevented the
portacaval shunt from gaining widespread acceptance in
the armamentarium of the surgeon. It was not established
as a routine operation until the pioneering efforts of Allen
Oldfather Whipple and his team at Columbia University in
New York in the early 1940s.

Eck reported in the Military Medical Journal of Russia in
1877 that he had joined the end of the portal vein to the
vena cava in eight dogs: "the animal recovers after such an
operation, its nutritional status improves gradually, and
remains in perfect health thereafter." Considering that of
the eight dogs he operated on, seven were dead within a
week afterwards, it would seem that the surgical trait of
forgetting one's bad results did not originate in this century!
The other dog lived for two and a half months and then
escaped to an unknown fate on the Russian steppes. Eck
himself was called up into active military service and faded
into obscurity. However, Hahn, working in Pavlov's laboratory, continued this study and found that ofthe dogs which
survived, many died later of what was called "meat intox-

Allen Whipple was encouraged to examine the possibility
of portacaval shunting for several reasons. First, he was
dissatisfied with the various devascularization operations
used to control bleeding varices, as they had both a high
mortality rate and a high rebleeding rate. Second, he was
aware of the portacaval shunts that the unrelated George
Whipple in Rochester New York had performed in dogs
with relative impunity. The freedom from "meat intoxicat i o n " in these dogs was due at least in part to the fact that
they were fed on meat-free extract. Indeed, this extract was
used in a research program which led to the discovery of
the role of vitamin B12 in pernicious anemia and to a
Nobel Prize for George Whipple (3).

t T h i s review is an original presentation prepared for the Surgical Grand
Rounds at Henry Ford Hospital on October 13, 1979. Dr. Jamieson was a
Visiting Professor with the Department of Surgery, Divisions of Vascular
Surgery and Cardiac and Thoracic Surgery on October 11-13, 1979. A
Senior Lecturer in Surgery at the University of Adelaide, Australia, Dr.
Jamieson is the author of numerous articles on cold sensitivity in
vascular disease, infected arteriografts, and venous disease.

But with the work of Allen Whipple the modern era of
shunting was born (4). It became obvious that the operation
of joining the portal to the systemic circulation was extremely effective in attaining its primary aim, that is, to stop
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bleeding from gastro-esophageal varices. As a result, enthusiasm for the portacaval shunt in portal hypertension
grew until the operation was being used not only to treat
patients who had bled from their varices (therapeutic
shunts), but also to treat patients who had varices and had
not bled from them (prophylactic shunts). Furthermore, the
operation was even being performed on patients with and
without varices who had ascites. In the early 1960s the use
of portacaval shunting reached an uncrftical zenith, but
ever since it has been on the decline.

toward the liver through the portal vein. There may be very
little flow in either direction in the portal vein, sometimes
blood flowing toward the liver and sometimes away; and
there may be hepatofugal blood flow in which the portal
vein acts as an outflow tract from the liver and in fact
decompresses hepatic sinusoids (9). Patients with no significant flow in either direction and no encephalopathy
should do best with traditional end-to-side portacaval
shunt. With this operation a shunt neither takes blood away
from the liver nor stops blood flowing out from the liver.
However, those patients with forward flow in the portal
vein might be expected to develop hepatic encephalopathy
since a vital source of blood supply to the liver has been
removed. Lastly, those patients in whom the portal vein is
acting as an outflow tract to the liver might be at risk of
developing ascites after an end-to-side portacaval shunt, as
the pressure in the liver would be increased when the
outflow tract was interrupted. Unfortunately, the situation is
probably more complex, as It has been shown that while
there is some correlation of prognosis with hemodynamic
staging, the correlation, in fact, is not as good as Child's
classification, which has been used for over ten years. One
of the difficulties has been to accurately determine preoperatively the amount and direction of portal flow in the
portal vein. One group's conclusion about hemodynamic
studies is that at present they are costly, time-consuming,
and unrewarding (10).

For one thing, improved medical management meant that
the operation was rarely indicated for ascites except when
a block in the hepatic venous circulation occurred, a very
uncommon situation. Also, when thoughtful clinicians
began to look more carefully at the natural history of portal
hypertension, it became clear that some patients never
bled from their varices and therefore could only lose by
having a major operation (5).
At this stage, several prospective, randomized trials were
set up to study both prophylactic and therapeutic portacaval shunts. With the former, when it was apparent that
patients who were shunted tended to have a poorer chance
of survival than those who were not shunted, the procedure
was abandoned as a prophylactic therapy for bleeding (6).
With the latter, although trials in the U.S. have shown a
trend in favor of shunted patients, there was a 7% statistical
probability that the result was due to chance (7). However,
the method of dying certainly differed in the two groups of
patients. In the shunted group, the patients died more often
of "meat intoxication", i.e., hepatic failure, while in the
unshunted group they died of hemorrhage from their
varices.

Poor risk groups
Several groups of patients with bleeding esophageal varices
have a high mortality rate after operation. First, there are
the patients who are acutely bleeding at the time of portacaval surgery. Operating in an emergency situation is
always hazardous. Even when patients are carefully selected, the operative mortality rate is in the 30% range; and
ifone takes unselected patients, the mortality rate is much
higher, usually in excess of 50% (11). For this reason, the
mesocaval shunt operation was introduced and probably
given its greatest boost by Theodore Drapanas. He reported
on a group of poor risk patients who had an operative
mortality of only 8% in 25 cases (12). But subsequent
reports have not been so optimistic; a recent prospective
study by Malt and his colleagues showed a 75% mortality
rate for the mesocaval shunt used in the emergency situation (13). Several retrospective series have shown high
mortality rates also. In other words, the figures look depressingly like those for portacaval shunt. Indeed, there
seems little reason, hemodynamically, why the figures
should be different. At present, it would appear that shunt
operations are contraindicated in acutely bleeding gastroesophageal varices. These patients should be treated by
standard medical measures such as blood replacement,
vasopressine infusions, either intravenously or intraar-

In an editorial in Gastroenterology in 1974, Harold Conn
said that " w e must learn either to select better who should
be shunted or to shunt better those we select." (7).

"Selecting Better"
Hemodynamic studies
Hemodynamic studies have been carried out to try to
achieve better selection of patients for surgery. Child's
clinical classification of patients into Class A, B, and C,
based on their liver function, has been quite useful in
predicting operative mortality (8). But it was hoped that
more accurately identifying the level of the obstruction to
portal flow and the degree and quality of portal flow might
have proved a better way to predict the outcome of surgery.
Hemodynamic studies have revealed that the flow of blood
in the portal vein in portal hypertension may be hepatopetal, so that in spite of increased pressure, blood still flows
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sclerosant therapy, percutaneous transhepatic obliteration
of varices, or staple gun gastro-esophageal transsection.
The same can be said for patients with acute alcoholic
hepatitis with hyaline necrosis, who also have a high
mortality rate with shunt operations (18).

terially, and a Sengstaken-Blakemore tube. If bleeding continues, in spite of these measures, then three choices are
available.

1. Sclerosant therapy
Avoiding shunt surgery altogether

The direct injection of sclerosant agents into bleeding
varices has been used in Europe for many years but is only
now beginning to gain greater acceptance elsewhere. In
Belfast, Rodgers and his group reported in a retrospective
study that they stopped bleeding in 93% of patients, although there was an in-hospital mortality rate of 26% (14).
Terblanche and his group in Cape Town recently published
a prospective study that showed similar figures; they were
able to stop bleeding in 92% of patients with a 25%
mortality rate (15). While these mortality rates may still
appear high, they must be compared with the mortality
rates of shunt operations in unselected patients in similar
circumstances.
2. Percutaneous transhepatic obliteration

Although direct operations on esophageal varices had been
used for many years, it was because of his dissatisfaction
with this approach that Allen Whipple inftially performed
portacaval shunts. Nevertheless, some groups have continued to use these operations and have recently reported
good results with them. Thus, Sugiura reported that in the
elective use of a thoraco-abdominal esophago-gastric devascularization, esophageal transsection, splenectomy and
selective vagotomy, and pyloroplasty, there was only a
2.6% mortality rate in 224 patients. In 52 patients who
were bleeding acutely he reported an 11.5% mortality rate.
Furthermore, the rebleeding rate was only 7% in his series
(19). Yamamoto has carried out a similar operation from an
abdominal approach. He performed an esophago-gastrectomy, splenectomy and trunkal vagotomy and pyloroplasty
electively in 64 patients with a mortality rate of 11% and a
rebleeding rate of only 14% (20). While these figures are
very impressive, the figures from the Chapel Hill group are
not. They carried out a similar procedure on 60 patients,
but reported a 35% operative mortality rate and a 50%
rebleeding rate (21). The cause ofthe cirrhosis and patient
selection methods may well explain some ofthe difference
in these figures, but, nevertheless, the discrepancy is very
large.

of varices

The placement of a catheter percutaneously through the
liver into radicles of the portal vein is an attractive technique because it allows the radiologist to selectively obliterate the veins w h i c h are causing b l e e d i n g . Several
substances have been used as obliterating material, among
them, gelfoam and cyanoacrylate. Although initial enthusiasm for this technique has been tempered somewhat by the
moderately high incidence of portal vein thrombosis following its use (16), nevertheless if sclerosant therapy fails or
is not available it would seem a better alternative than a
shunt operation in an acutely bleeding situation.
3. Staple gun gastro-esophageal

transsection

"Shunting Better"

This is but a variant of the older operation of esophageal
transsection and/or under-running of varices. However, it
is quicker than those operations and produces a better
gastro-esophageal anastomosis. It can be accomplished
with a reasonably low mortality, although it has not yet
been properly assessed for acutely bleeding patients (17). If
sclerosant therapy or percutaneous obliteration cannot be
carried out, this operation may be the most conservative
way to produce the desired result of stopping bleeding in
the emergency situation.

At present, two operations are the main contenders for
better shunts. Most people agree that if significant blood
flows up the portal vein toward the liver, then that blood
supply should not be removed. The first o f t h e new operations attempts to keep blood flowing to the liver by arterializing the portal vein stump, while the second leaves
intact the superior mesenteric vein flow to the portal vein.

Besides acutely bleeding patients, two other categories of
patients do badly with shunt surgery: patients with alcoholic hepatitis and hyaline necrosis, and patients with
Child's Class C liver function. If a patient falls into this latter
group in spite of a nutritionally adequate diet and abstinence from alcohol, then again the operative mortality rate
with shunt operations is prohibitively high (5). Since the life
expectancy of such a patient is short, the same procedures
as for emergency bleeding should be considered, that is.

Maillard has reported a standard portacaval shunt followed
by an anastomosis of the splenic artery to the portal vein
stump (22). Adamsons has also used this technique and
recently reported on lower flow arterialization using microvascular techniques to anastomose the right gastro-epiploic
artery to the portal vein stump (23). However, neither of
these techniques has yet found widespread acceptance.
The operation which has slowly gained acceptance is the
selective distal splenorenal shunt.

Arterialization of the portal vein
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Selective distal splenorenal shunt (Warren shunt)

shunt should not be attempted, e.g., an absent left kidney,
thrombosed renal vein, or thrombosed splenic vein. In the
past, severe ascites was considered an absolute contraindication to the operation, but Warren now uses a peritoneovenous shunt in these patients after constructing a
distal splenorenal shunt (personal communication, 1979).

In 1967 Warren, Zeppa, and Fomon (24) first described this
operation in which the splenic vein is dissected from the
bed of the pancreas, divided near its central end, turned
down, and anastomosed end-to-side to the left renal vein.
The left gastric (coronary) vein, the right gastro-epiploic
vein, and any other venous connections between the portal
system and the stomach are then divided so that the
superior mesenteric vein flow to the liver remains intact.
This operation has met with growing acceptance, as both
retrospective and prospective studies have shown that the
incidence of hepatic encephalopathy is indeed lower following the procedure when compared with other portasystemic shunts. The rebleeding rate also remains
acceptably low (25,26).

There are other conditions in which the shunt may prove
difficult or inappropriate; for example, severe chronic pancreatitis can make the splenic vein extremely difficult to
dissect from the pancreas. A splenic vein with a large
convexity cephalad requires a much longer dissection from
the pancreas in order to get a section of vein long enough
to bring it down to the renal vein. Finally, in a small number
of patients who have an extremely small splenic vein, it
would seem inappropriate to join such a vein to the left
renal vein in order to decompress gastro-esophageal
varices.

We have used this operation in a small groupof 18 patients
with three postoperative deaths: a Child's Class B patient
who developed infected ascites and died of overwhelming
sepsis; a Child's Class B patient who died of massive
bleeding from varices on the 12th postoperative day in
spite of a widely patent shunt revealed at autopsy; and a
Child's Class C patient who developed progressive liver
failure and died on the 27th postoperative day. Of the 15
remaining patients, one developed an early shunt thrombosis and had a mesocaval shunt constructed, while another died two years after the operation of liver failure due
to continuing alcoholism. Thirteen patients are alive after
12-48 months, follow-up. They have had no recurrent
hemorrhage, and one patient has had overt portal systemic
encephalopathy of mild degree.

Although it has not yet been shown that patients live longer
after this operation, we believe that its lower incidence of
encephalopathy currently makes it the best operation in
good risk patients.

Summary
We believe a selective approach to bleeding esophageal
varices may produce improved results in the future. In the
emergency situation and in patients with poor liver function, shunt operations should be avoided; and injection
sclerotherapy or transhepatic obliteration of varices should
be undertaken to stop bleeding. In elective surgery, with
good risk patients, the Warren shunt currently appears to
be the best operation to prevent bleeding from varices.

Although our experience is limited, we feel in a position to
comment about the operation. For some conditions this
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